Cargando…
Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Urologia
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747027/ https://www.ncbi.nlm.nih.gov/pubmed/36173410 http://dx.doi.org/10.1590/S1677-5538.IBJU.2022.06.02 |
_version_ | 1784849499081932800 |
---|---|
author | Averbeck, Marcio Augusto |
author_facet | Averbeck, Marcio Augusto |
author_sort | Averbeck, Marcio Augusto |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9747027 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Sociedade Brasileira de Urologia |
record_format | MEDLINE/PubMed |
spelling | pubmed-97470272022-12-16 Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity Averbeck, Marcio Augusto Int Braz J Urol Update in Urology Sociedade Brasileira de Urologia 2022-11-01 /pmc/articles/PMC9747027/ /pubmed/36173410 http://dx.doi.org/10.1590/S1677-5538.IBJU.2022.06.02 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Update in Urology Averbeck, Marcio Augusto Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity |
title | Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity |
title_full | Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity |
title_fullStr | Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity |
title_full_unstemmed | Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity |
title_short | Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity |
title_sort | editorial comment: solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity |
topic | Update in Urology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747027/ https://www.ncbi.nlm.nih.gov/pubmed/36173410 http://dx.doi.org/10.1590/S1677-5538.IBJU.2022.06.02 |
work_keys_str_mv | AT averbeckmarcioaugusto editorialcommentsolifenacintreatmentafterintradetrusorinjectionswithbotulinumtoxininpatientswithneurogenicdetrusoroveractivity |